PPD Inc. Creating 86 Jobs in Wayne, Pennsylvania
11/03/2010
"With a large concentration of pharmaceutical, and biotechnology companies based in the northeast United States, expanding our laboratory operations in Wayne builds on our ability to serve clients in this region more effectively," said Lee Babiss, executive vice president of global laboratory services for PPD. "We are pleased to continue our growth in Wayne and appreciate the strong support we have received from Governor Rendell and Pennsylvania."
The Chester County Economic Development Council worked with the company and the Governor's Action Team to secure $608,000 in funding that includes a $275,000 opportunity grant, $74,700 in job training assistance, and $258,000 in job creation tax credits.
PPD conducts drug discovery, development, and lifecycle management to pharmaceutical and biotech companies around the world. The Wayne facility includes a vaccines and biologics lab.
Project Announcements
Kikkoman Foods Plans Jefferson, Wisconsin, Operations
04/26/2024
BWX Technologies Expands Cambridge, Ontario, Nuclear Production Operations
04/26/2024
Greenheck Group Plans Knoxville, Tennessee, Operations
04/26/2024
Local Bounti Plans Pasco, Washington, Indoor Agricultural Operations
04/26/2024
Innovative Construction Group Plans Siler City, North Carolina, Production Operations
04/26/2024
Crystal Window and Door Systems Plans Mansfield, Texas, Headquarters-Production Operations
04/25/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024